Hiromichi Kimura

Investment Director
2018
Led and achieved 11 qualified investments to early stage Bioventures and built 3 strategic LP partnerships with top 1&2 venture capitals from deal due diligence to execution of agreements under my supervision last 2 years. Some of Bioventures have reached out to Pharma deals. Organization management to upgrade to professional global standard including budget, people, legal, IP, venture capital tasks.

2014 - 2018

Senior Director
2014 - 2018
Post merger integration as cross-functional leadership in Research and Manufacture, IP & legal (Ganymed, Ogeda, Quethera), Oncology drug discovery, Management of Local and Global research collaborations including CRUK, Translational Science, Project based partnership Management: People, Budget, Legal documents, External relationships Supervised/managed over 10 oncology programs Co-founded Kyoto University-Astellas incubator research station in Kyoto University.

2013 - 2014

Dual position/Associate Director/Research head/Head of Department in Pharmacology
2013 - 2014
Protein homeostasis in Oncology

2007 - 2014

Associate Director/Research head/Head of Department in Pharmacology (SRC)
2007 - 2014
Drug discovery (generated first in class 10+ programs as lead and Head), Translational Science in Oncology, Global organizational collaboration with Takeda San Francisco, Takeda San Diego, and Millennium: Takeda Oncology Management: People, Budget, Organization, Annual planning, cross-functional projects

2001 - 2007

Postdoctoral Research Associate (Tom Curran, FRS lab)
2001 - 2007
Academic independent position (2006-2007) Basic and Translational Science in Oncology Long-term collaboration with Genentech (Fred de Sauvage) and Curis (Lee Rubin) AACR Scholar in Awards (2003, 2006, 2007) International Congress Biochemistry and Molecular Biology Young Scientist Award (2006) International Congress Biochemistry and Molecular Biology Best Presentation Award (2006)

2000 - 2002

Postdoctoral Research Fellow of JSPS for Young Scientist
2000 - 2002
Molecular biology, Cellular proliferation, Epigenetics

Ph.D. Scientist, Investor, Board Director (Casma, DEM Bio, NeoPhore, Others), Advisory member (Top tier venture funds), Academic appointment (The University of Tokyo)